Taking Family Cancer History May Release Emotions

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 9
Volume 7
Issue 9

SAN FRANCISCO--A thorough and accurate family history, going back at least four generations, is one of the most effective tools for establishing genetic cancer risk in a patient, Andrea Fishbach, MS, MPH, of Kaiser Permanente, San Francisco, said at the American Cancer Society’s 2nd National Conference on Cancer Genetics. But counselors should be aware that taking such a history can release strong emotions in the patient.

SAN FRANCISCO--A thorough and accurate family history, going back at least four generations, is one of the most effective tools for establishing genetic cancer risk in a patient, Andrea Fishbach, MS, MPH, of Kaiser Permanente, San Francisco, said at the American Cancer Society’s 2nd National Conference on Cancer Genetics. But counselors should be aware that taking such a history can release strong emotions in the patient.

A family history, she said, can reveal much about family dynamics, showing the social relationships within the family and how information flows. "Behind these symbols in the family tree are people and relationships," she said. "You have to remember that during the family history gathering." She recalled one patient who burst into tears after seeing on a chart all the members of her family who had died of cancer. "She had never grieved for them collectively," Ms. Fishbach said.

Other emotional issues may come up during a family history. Patients may be fearful of having a genetic disease, afraid of the social stigma of carrying a cancer gene, or wary of having to make a decision about genetic testing.

It is vital to verify the facts in the history through pathology reports, hospital records, and histologic sections, if available, Ms. Fishbach said, especially concerning the patient’s remote relatives. A 1985 study by Love, for example, found that patients often could name the primary site of their primary relatives’ cancer, but cancer in remote relatives was significantly underreported.

Is Grief Counseling Necessary?

As the patient and clinician delve into the family history, the clinician can identify if genetic counseling is needed and also should consider if grief counseling would be useful. "Often there is grief and guilt about being part of a family with a cancer gene. We want to instill hope with counseling, reinforce coping methods, and teach new ways of coping," Ms. Fishbach said.

Another goal of counseling, she said, is to promote family communication so that each member can make accurate decisions about his or her risk.

Recent Videos
Once a patient-specific dose is determined, an all-oral combination of revumenib plus decitabine/cedazuridine and venetoclax may be “very good” in AML.
Patients with lung cancer who achieve a complete response with neoadjuvant therapy may not experience additional benefit with adjuvant immunotherapy.
Numerous trials have displayed the evolution of EGFR inhibition alone or with chemotherapy/radiation in the EGFR-mutated lung cancer space.
2 experts are featured in this series.
Although high grade adverse effects are infrequent among patients undergoing treatment for SCLC, CRS and ICANS may occur in higher frequencies.
Two experts are featured in this series.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to look forward to at the 67th Annual ASH Meeting in Orlando.
4 experts are featured in this series.
Based on a patient’s SCLC subtype, and Schlafen 11 status, patients will be randomly assigned to receive durvalumab alone or with a targeted therapy in the S2409 PRISM trial.
4 experts are featured in this series.
Related Content